Article
Predicting vaccine effectiveness in Mpox
2023-11-24
Abstract excerpt
The Modified Vaccinia Ankara vaccine developed by Bavarian Nordic (MVA-BN) was widely deployed to prevent Mpox during the 2022 global outbreak. This vaccine was initially approved for Mpox based on its reported immunogenicity and effectiveness in animal models, rather than evidence of clinical efficacy. However no validated correlate of protection after vaccination has been identified. Here we performed a systemat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6ba7752f-c9cb-5f4e-97f3-df71fa15fc01
- DOI
- 10.1101/2023.11.23.23298850
